AXIM (AXIM Biotechnologies) E10: $-0.13 (As of Jun. 2025)


What is AXIM Biotechnologies E10?

AXIM Biotechnologies AXIM -16.00% E10 is $-0.13 as of Jun. 2025. The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

AXIM Biotechnologies's adjusted earnings per share data for the three months ended in Jun. 2025 was $0.001. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.13 for the trailing ten years ended in Jun. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-25), AXIM Biotechnologies's current stock price is $0.0042. AXIM Biotechnologies's E10 for the quarter that ended in Jun. 2025 was $-0.13. AXIM Biotechnologies's Shiller PE Ratio of today is .


AXIM Biotechnologies  (OTCPK:AXIM) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


AXIM Biotechnologies E10 Related Terms


AXIM Biotechnologies E10 Historical Data

* Premium members only.

The historical data trend for AXIM Biotechnologies's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AXIM Biotechnologies E10 Chart

AXIM Biotechnologies Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.13 -0.13 -0.13 0.00

AXIM Biotechnologies Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.13 -0.13 0.00 -0.14 -0.13

AXIM vs HEPA, SCNI, BZYR: E10 Comparison

For the Biotechnology subindustry, AXIM Biotechnologies's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AXIM Biotechnologies Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AXIM Biotechnologies's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where AXIM Biotechnologies's Shiller PE Ratio falls into.



AXIM Biotechnologies E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, AXIM Biotechnologies's adjusted earnings per share data for the three months ended in Jun. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2025 (Change)*Current CPI (Jun. 2025)
=0.001/322.5610*322.5610
=0.001

Current CPI (Jun. 2025) = 322.5610.

AXIM Biotechnologies Quarterly Data

per share eps CPI Adj_EPS
201506 -0.040 238.638 -0.054
201509 -0.040 237.945 -0.054
201512 -0.170 236.525 -0.232
201603 -0.020 238.132 -0.027
201606 -0.050 241.018 -0.067
201609 -0.070 241.428 -0.094
201612 -0.020 241.432 -0.027
201703 -0.010 243.801 -0.013
201706 -0.010 244.955 -0.013
201709 -0.030 246.819 -0.039
201712 -0.030 246.524 -0.039
201803 -0.050 249.554 -0.065
201806 -0.030 251.989 -0.038
201809 -0.020 252.439 -0.026
201812 -0.020 251.233 -0.026
201903 -0.040 254.202 -0.051
201906 -0.030 256.143 -0.038
201909 -0.010 256.759 -0.013
201912 -0.020 256.974 -0.025
202003 -0.030 258.115 -0.037
202006 0.000 257.797 0.000
202009 -0.020 260.280 -0.025
202012 -0.020 260.474 -0.025
202103 -0.010 264.877 -0.012
202106 -0.030 271.696 -0.036
202109 -0.030 274.310 -0.035
202112 -0.060 278.802 -0.069
202203 -0.010 287.504 -0.011
202206 -0.010 296.311 -0.011
202209 -0.012 296.808 -0.013
202212 -0.006 296.797 -0.007
202303 -0.013 301.836 -0.014
202306 -0.020 305.109 -0.021
202309 0.001 307.789 0.001
202312 -0.008 306.746 -0.008
202403 -0.001 312.332 -0.001
202406 -0.010 314.175 -0.010
202412 0.000 315.605 0.000
202503 -0.001 319.799 -0.001
202506 0.001 322.561 0.001

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-0.13 mean?
AXIM Biotechnologies (AXIM) has a E10 of $-0.13 as of Jun. 2025. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on AXIM Biotechnologies and its competitors.
Is AXIM Biotechnologies' E10 too high?
AXIM Biotechnologies' current E10 is $-0.13.
How does AXIM Biotechnologies' E10 compare to HEPA and SCNI?
AXIM Biotechnologies' E10 of $-0.13 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on AXIM Biotechnologies and its competitors. AXIM Biotechnologies's current E10 is $-0.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AXIM Biotechnologies stock overvalued right now?
AXIM Biotechnologies (AXIM) has a current E10 of $-0.13. The current E10 is $-0.13. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For AXIM Biotechnologies (AXIM), the current E10 is $-0.13 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AXIM Biotechnologies Business Description

Address 6048 Cornerstone Court West, Suite E1, San Diego, CA, USA, 92121
AXIM Biotechnologies Inc is a integrated research and development company and developer of diagnostic healthcare solutions serving to enhance the health of people. The company focuses on improving the landscape for the diagnosis of ophthalmological conditions such as Dry Eye Disease through rapid diagnostic tests. Additionally, The company owns IP and has conducted research on SARS-CoV-2 (COVID-19) rapid neutralizing antibody tests to detect levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells.